In addition, knockdown of PRMT1 can lead to the G1-S phase arrest of the cell cycle, proliferation inhibition and apoptosis induction in glioma cells in vitro and in xenografts, suggesting a potential oncogenic role for PRMT1 in gliomas [19]. Here, PRMT1 is linked to central nervous system cancer.